Global Next-Generation Sequencing (NGS) Market Report 2019 – World Market Projected to Surpass $25 Billion by 2026, Rising at a CAGR of 20.6% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Next-Generation Sequencing (NGS) Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.

The Global Next-Generation Sequencing (NGS) market is expected to reach $25.09 billion by 2026 growing at a CAGR of 20.6% from 2018 to 2026.

Low cost, high accuracy & speed, and exact outcomes even from low sample input are the fundamental advantages it offers over Sanger’s sequencing technique. It is utilized to execute different applications for example, biomarker discovery, oncology studies, personalized medicine, agricultural & animal research, and others. It has streamlined nucleotide analysis and has generally replaced conventional tools of genomics, particularly microarray efficiently. Consequently, these aforementioned factors help in expanding the market share.

Factors such as rise in technological advancements and increase in partnerships & collaborations are driving the market growth. Though, lack of skilled professionals, and ethical & legal limitations are projected to inhibit the growth of the market. Moreover, cloud computing as a potential data management service and lucrative opportunities in emerging markets may provide ample opportunities for the market growth.

By end user, academic institutes & research centers segment acquired significant growth in the market owing to the increasing number of collaborations between the market players and academic & research institutions and on the account of wide usage of these methodologies in research and Ph.D. projects, on-site bioinformatics courses, and workshops across regions, and the development of cost-efficient products and services for researchers is leading to the market growth.

The key vendors mentioned are 10x Genomics, Agilent Technologies Inc, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, BGI, Eurofins Scientific, F. Hoffmann-La Roche AG, Genewiz, Illumina Inc, Macrogen Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, Perkinelmer Inc, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in this Report

• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Key Topics Covered

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Next-Generation Sequencing (NGS) Market, By Disease

5.1 Introduction

5.2 Rare Disease Diagnostics

5.3 Cardiovascular

5.4 Other Diseases

6 Global Next-Generation Sequencing (NGS) Market, By Service

6.1 Introduction

6.2 Sequencing Services

6.3 Animal & Plant Sequencing

6.4 Gene Regulation Services

6.5 Human Genome Sequencing Services

6.6 Microbial Genome – based Sequencing Services

6.7 Single Cell Sequencing Services

7 Global Next-Generation Sequencing (NGS) Market, By Type of Sequencing

7.1 Introduction

7.2 CHIP Sequencing

7.3 De Novo Sequencing

7.4 Illumina Sequencing

7.5 Methyl Sequencing

7.6 Pre-Sequencing

7.7 RNA Sequencing

7.8 Targeted Sequencing & Resequencing

7.9 Whole Exome Sequencing

7.10 Whole Genome Sequencing

8 Global Next-Generation Sequencing (NGS) Market, By Informatics

8.1 Introduction

8.2 Primary and Secondary Data Analysis Tools

8.3 NGS Informatics Services

8.4 Computing

8.5 Storage

8.6 LIMS (Laboratory Information Management System)

8.7 Biological Interpretation and Reporting Tools

9 Global Next-Generation Sequencing (NGS) Market, By Product

9.1 Introduction

9.2 Reagents & Consumables

9.3 Instruments

9.4 Platforms

9.5 Software

9.6 Services

10 Global Next-Generation Sequencing (NGS) Market, By Technology

10.1 Introduction

10.2 454 Technology

10.3 DNA Nano Ball Sequencing

10.4 Ion Semiconductor Sequencing

10.5 Ion Torrent Sequencing

10.6 Ion Semiconductor Sequencing

10.7 Massively Parallel Signature Sequencing (MPSS)

10.8 Nanopore Sequencing

10.9 Pyrosequencing

10.10 Reversible Terminator Sequencing

10.11 Sequencing by Ligation (SBL)

10.12 Sequencing By Synthesis

10.13 Sequencing by Synthesis (SBS)

10.14 Single Molecule Real Time (SMRT) Sequencing

10.15 Single-Molecule Real-Time Sequencing

10.16 Supported Oligonucleotide Ligation and Detection (SOLiD)

11 Global Next-Generation Sequencing (NGS) Market, By Application

11.1 Introduction

11.2 Agrigenomics & Forensics

11.3 Biomarker Discovery and Cancer

11.4 Cardiovascular

11.5 Clinical Investigation

11.6 Consumer Genomics

11.7 Drug Discovery

11.8 Emerging Application

11.9 Forensics

11.20 Genetic Analysis

11.21 Hereditary Disease Detection

11.22 HLA Typing/Immune System Monitoring

11.23 Human Leukocyte Antigen (HLA) Testing

11.24 Infectious Disease Diagnostics

11.25 Life Science

11.26 Metagenomics, Epidemiology & Drug Development

11.27 Oncology

11.28 Pharmaceuticals

11.29 Precision Medicine

11.30 Reproductive Health

12 Global Next-Generation Sequencing (NGS) Market, By End User

12.1 Introduction

12.2 Academic Institutes & Research Centers

12.3 Agriculture and Animal Research

12.4 Biotech and Pharmaceutical Firms

12.5 Cloud Service Providers

12.6 Contract Research Organization (CROs)

12.7 Diagnostics/Infectious Diseases

12.8 Drug Discovery/Personalized Medicine

12.9 Genetic Screening

12.20 Government Research Institutes

12.21 Hospitals & Clinics

12.22 Pesticides

12.23 Reference Laboratories

12.24 Research Institutions

13 Global Next-Generation Sequencing (NGS) Market, By Geography

13.1 Introduction

13.2 North America

13.3 Europe

13.4 Asia Pacific

13.5 South America

13.6 Middle East & Africa

14 Strategic Benchmarking

15 Vendors Landscape

15.1 10x Genomics

15.2 Agilent Technologies Inc.

15.3 Beckman Coulter (A Subsidiary of Danaher)

15.4 Becton, Dickinson & Company

15.5 BGI

15.6 Eurofins Scientific

15.7 F. Hoffmann-La Roche AG

15.8 Genewiz

15.9 Illumina Inc.

15.10 Macrogen Inc.

15.11 Oxford Nanopore Technologies Ltd.

15.12 Pacific Biosciences of California Inc.

15.13 Perkinelmer Inc.

15.14 Qiagen N.V.

15.15 Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/6lazc8

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900